122 related articles for article (PubMed ID: 30150445)
1. A Case of a Pregnant Woman Diagnosed as Having
Komura M; Yagishita S; Nakamura K; Arano N; Takeshige T; Muraki K; Nagashima O; Izumi H; Tomita S; Sasaki S; Takahashi K
In Vivo; 2018; 32(5):1205-1209. PubMed ID: 30150445
[TBL] [Abstract][Full Text] [Related]
2. Ovarian Metastases from ALK-rearranged Lung Adenocarcinoma: A Case Report and Literature Review.
Sasano H; Sekine A; Hirata T; Iwamoto K; Itou Y; Itani H; Kondou S; Tokui T; Tanigawa M
Intern Med; 2018 Nov; 57(22):3271-3275. PubMed ID: 29984766
[TBL] [Abstract][Full Text] [Related]
3. Lung adenocarcinoma during pregnancy: clinical case and literature review.
Bellido C; Barbero P; Forcén L; Blanco M; Alonso-Riaño M; Galindo A
J Matern Fetal Neonatal Med; 2019 Oct; 32(19):3300-3302. PubMed ID: 29618241
[TBL] [Abstract][Full Text] [Related]
4. ALK-rearranged lung squamous cell carcinoma responding to alectinib: a case report and review of the literature.
Mamesaya N; Nakashima K; Naito T; Nakajima T; Endo M; Takahashi T
BMC Cancer; 2017 Jul; 17(1):471. PubMed ID: 28683775
[TBL] [Abstract][Full Text] [Related]
5. Alectinib is effective, safe and tolerable in an adolescent with stage IVB ALK-rearranged adenocarcinoma of the lung.
Balzer BWR; Loo C; Wegner EA; Nath CE; Lee S; Smith C; Lewis CR; Trahair TN; Anazodo AC
Pediatr Hematol Oncol; 2018; 35(7-8):415-421. PubMed ID: 30526220
[TBL] [Abstract][Full Text] [Related]
6. Use of ALK Immunohistochemistry for Optimal Therapeutic Strategy of Pulmonary Large-cell Neuroendocrine Carcinoma and Identification of a Novel
Shimizu N; Akashi Y; Fujii T; Shiono H; Yane K; Kitahara T; Ohta Y; Kakudo K; Wakasa T
Anticancer Res; 2019 Jan; 39(1):413-420. PubMed ID: 30591488
[TBL] [Abstract][Full Text] [Related]
7. VIT-ALK, a Novel Alectinib-Sensitive Fusion Gene in Lung Adenocarcinoma.
Hu S; Li Q; Peng W; Feng C; Zhang S; Li C
J Thorac Oncol; 2018 May; 13(5):e72-e74. PubMed ID: 29703539
[No Abstract] [Full Text] [Related]
8. ALK-positive adenocarcinoma of the lung expressing neuroendocrine markers and presenting as a "pituitary adenoma".
Mengoli MC; Bertolini F; Maur M; Barbieri F; Longo L; Gasparri P; Tiseo M; Rossi G
Pathologica; 2017 Dec; 109(4):408-411. PubMed ID: 29449735
[TBL] [Abstract][Full Text] [Related]
9. First Case Report of Pregnancy on Alectinib in a Woman With Metastatic ALK-Rearranged Lung Cancer: A Case Report.
Scarfone G; Fumagalli M; Imbimbo M; Ceruti T; Cribiù FM; Di Loreto E; D'Incalci M; Facchin F; Fontana C; Garassino MC; Peccatori FA; Persico N; Signorelli D; Zucchetti M
J Thorac Oncol; 2021 May; 16(5):873-877. PubMed ID: 33795207
[TBL] [Abstract][Full Text] [Related]
10. Advanced adenocarcinoma of the lung: comparison of CT characteristics of patients with anaplastic lymphoma kinase gene rearrangement and those with epidermal growth factor receptor mutation.
Choi CM; Kim MY; Hwang HJ; Lee JB; Kim WS
Radiology; 2015 Apr; 275(1):272-9. PubMed ID: 25575117
[TBL] [Abstract][Full Text] [Related]
11. Detection of Anaplastic Lymphoma Kinase-Rearranged Mesothelioma Cells in Ascites by Companion Diagnostics.
Konishi M; Kanyama T; Maeno K; Miyagawa C; Minamiguchi S; Katsushima H; Shimada T
Acta Cytol; 2020; 64(4):378-385. PubMed ID: 31661685
[TBL] [Abstract][Full Text] [Related]
12. Hemorrhagic Brain Metastases in a Patient with Anaplastic Lymphoma Kinase (ALK)-Rearranged Invasive Mucinous Adenocarcinoma of the Lung.
Shi M; Xu H; DiPoto Brahmbhatt A; Gonzalez-Toledo E; Georgescu MM
Am J Case Rep; 2018 Jan; 19():99-104. PubMed ID: 29371584
[TBL] [Abstract][Full Text] [Related]
13. P-glycoprotein Mediates Ceritinib Resistance in Anaplastic Lymphoma Kinase-rearranged Non-small Cell Lung Cancer.
Katayama R; Sakashita T; Yanagitani N; Ninomiya H; Horiike A; Friboulet L; Gainor JF; Motoi N; Dobashi A; Sakata S; Tambo Y; Kitazono S; Sato S; Koike S; John Iafrate A; Mino-Kenudson M; Ishikawa Y; Shaw AT; Engelman JA; Takeuchi K; Nishio M; Fujita N
EBioMedicine; 2016 Jan; 3():54-66. PubMed ID: 26870817
[TBL] [Abstract][Full Text] [Related]
14. A Case of Simultaneously Diagnosed Lung Adenocarcinoma and Endobronchial Inflammatory Myofibroblastic Tumor with Two Distinct Types of ALK Translocation.
Zhao S; Liu W; Li S; Shi T; Chen Q; Li Q; Sun L; Ren D; Song Z; Huang C; Xu S
Cancer Res Treat; 2021 Apr; 53(2):601-606. PubMed ID: 33091968
[TBL] [Abstract][Full Text] [Related]
15. An ALK-positive lung adenocarcinoma with gastric and skin metastasis: a case report and literature review.
Duan X; Zhao X; Wang S
Ann Palliat Med; 2021 May; 10(5):5797-5807. PubMed ID: 32819126
[TBL] [Abstract][Full Text] [Related]
16. ALK-rearranged lung adenocarcinoma transformation into high-grade large cell neuroendocrine carcinoma: Clinical and molecular description of two cases.
Fares AF; Lok BH; Zhang T; Cabanero M; Lau SCM; Stockley T; Patel D; Bradbury PA; Sacher A; Yasufuku K; Morash BA; Sabatini PJB; Nguyen LN; Leighl NB; Tsao MS; Shepherd FA; Liu G; Martins-Filho SN; Pal P
Lung Cancer; 2020 Aug; 146():350-354. PubMed ID: 32546380
[No Abstract] [Full Text] [Related]
17. An autopsy case of anaplastic lymphoma kinase-positive lung cancer exacerbated in a short period of time: a case report.
Takeda M; Sato K; Sakamoto S; Suzuki M; Izumiya Y; Kumagai N; Sudo K; Okuda Y; Asano M; Sano M; Omori Y; Nakayama K
J Med Case Rep; 2019 Apr; 13(1):118. PubMed ID: 31030664
[TBL] [Abstract][Full Text] [Related]
18. SMPD3-ALK: A novel ALK fusion gene in lung adenocarcinoma.
Liang Y; Wang Y; Wang W; Zhao J; Xu M; Zheng M
Clin Genet; 2021 Mar; 99(3):488-489. PubMed ID: 33556194
[TBL] [Abstract][Full Text] [Related]
19. The use of alectinib in the first-line treatment of anaplastic lymphoma kinase-positive non-small-cell lung cancer.
Gadgeel SM
Future Oncol; 2018 Aug; 14(18):1875-1882. PubMed ID: 29536761
[TBL] [Abstract][Full Text] [Related]
20. Anaplastic lymphoma kinase (ALK)-expressing Lung Adenocarcinoma with Combined Neuroendocrine Component or Neuroendocrine Transformation: Implications for Neuroendocrine Transformation and Response to ALK-tyrosine Kinase Inhibitors.
Sim J; Kim H; Hyeon J; Choi Y; Han J
J Korean Med Sci; 2018 Apr; 33(15):e123. PubMed ID: 29629521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
